Bone Biologics Corporatio... (BBLG)
NASDAQ: BBLG
· Real-Time Price · USD
2.21
-0.14 (-5.96%)
At close: Aug 15, 2025, 2:55 PM
Bone Biologics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.76 | -2.74 | -5.95 | -2.68 | -2.43 | -2 | -1.74 | -3.29 | -0.84 | 2.58 | -6.67 | -23.13 | -31.26 | -153.21 | -83.05 | -20.43 | -23.02 |
PEG Ratio | 0.04 | -0.09 | -0.02 | 0.05 | 0.02 | 0.00 | 0.29 | 0.04 | 0.01 | -0.01 | -0.04 | 0.72 | 0.29 | 0.08 | 1.10 | -1.53 | 0.71 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 5.25 | 4.78 | 5.91 | 2.89 | 2.30 | 4.27 | 3.51 | 4.09 | 4.50 | 1.55 | 7.39 | 7.76 | 14.27 | 16.59 | -11.18 | -2.75 | -2.82 |
P/FCF Ratio | -16.5 | -12.31 | -39.16 | -9.39 | -6.47 | -6.16 | -5.21 | -6.41 | -9.25 | -4.73 | -82.33 | -120.5 | -100.09 | -583.82 | -608.71 | -63.23 | -310.85 |
P/OCF Ratio | -16.5 | -12.31 | -39.16 | -9.39 | -6.47 | -6.16 | -5.21 | -6.41 | -9.25 | -4.73 | -82.33 | -120.5 | -100.09 | -583.82 | -608.71 | -63.23 | -310.85 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.84 | -0.85 | -0.84 |
Quick Ratio | 12.59 | 10.22 | 14.87 | 11.22 | 25.32 | 4.89 | 4.21 | 3.95 | 1.69 | 3.33 | 6.51 | 80.11 | 110.97 | 66.81 | 0.00 | 0.00 | 0.01 |
Current Ratio | 12.59 | 10.22 | 14.87 | 11.22 | 23.32 | 4.50 | 4.21 | 3.95 | 1.69 | 3.33 | 6.51 | 80.11 | 110.97 | 66.81 | 0.00 | 0.00 | 0.01 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.76 | n/a | n/a | n/a | -31.11 | -0.82 | -0.89 | -0.72 |
Return on Equity | -0.35 | -0.44 | -0.25 | -0.27 | -0.24 | -0.53 | -0.51 | -0.31 | -1.34 | 0.15 | -0.28 | -0.08 | -0.11 | -0.03 | 0.03 | 0.03 | 0.03 |
Return on Assets | -0.32 | -0.39 | -0.23 | -0.25 | -0.23 | -0.41 | -0.39 | -0.23 | -0.55 | 0.11 | -0.23 | -0.08 | -0.11 | -0.03 | -9.72 | -110.86 | -6.07 |
Return on Invested Capital | -0.36 | -0.45 | -0.25 | -0.28 | -0.25 | -0.4 | -0.55 | -0.53 | -1.14 | -0.22 | -0.28 | -0.08 | -0.11 | -0.07 | 0.10 | 0.11 | 0.08 |
Dividend Yield | n/a | n/a | 0.14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | -3.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |